AstraZeneca
AZN
#46
Rank
HK$2.474 T
Marketcap
HK$1,596
Share price
-0.88%
Change (1 day)
32.81%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): HK$41.71

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$41.86. In 2024 the company made an earnings per share (EPS) of HK$35.52 an increase over its 2023 EPS that were of HK$30.04.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$41.7117.43%
2024HK$35.5218.23%
2023HK$30.0481.13%
2022HK$16.59631.03%
2021HK$2.27-88.11%
2020HK$19.09136.89%
2019HK$8.06-39.41%
2018HK$13.30-28.27%
2017HK$18.54-14.37%
2016HK$21.6524.11%
2015HK$17.45127.55%
2014HK$7.67-51.96%
2013HK$15.96-58.95%
2012HK$38.88-32.2%
2011HK$57.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.13 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.58 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.64-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.33-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.09 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.16-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$85.98 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.16 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.24-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.48-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK